{
    "SPADE_UN_18938": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_18938",
            "Peptide Name": "Dermaseptin-PS4 (Der-PS4, XXA, UCLL1c; natural AMPs; frog, amphibians, animals)",
            "Source": "skin secretion, Painted-belly leaf frog,Phyllomedusa sauvagii, South America",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "ALWKTLLKHVGKAAGKAALNAVTDMVNQ",
            "Sequence Length": 28,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal",
                "Antifungal",
                "Anti-MRSA",
                "Anticancer"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2949.47,
            "PI": 10.0,
            "Hydrophobicity": 0.16,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Chen D, Zhou X, Chen X, Huang L, Xi X, Ma C, Zhou M, Wang L, Chen T.2019",
                    "Reference": "Molecules. 2019 Aug 16;24(16):2974. doi: 10.3390/molecules24162974.PubMed",
                    "Title": "Evaluating the Bioactivity of a Novel Antimicrobial and Anticancer Peptide, Dermaseptin-PS4(Der-PS4), from the Skin Secretion of Phyllomedusa sauvagii."
                }
            ],
            "Frequent Amino Acids": "AKL",
            "Absent Amino Acids": "CEFIOPRSUY",
            "Basic Residues": 5,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 15,
            "Polar Residues": 19,
            "Positive Residues": 5,
            "Negative Residues": 1,
            "Net Charge": 4,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (96.43%) toDermaseptin-DI2A: 21%, L=K: 14%. Differing from AP00958 only at residue 9 (H vs. N). GRAVY: 0.164; mol wt: 2949.503; mol formula: C132H225N36O36S1; mol ex coeff: 5550.Activity: active against  S. aureus ATCC 12600 MRSA ATCC BAA-1720 (MIC 4-8 uM), E. faecalis ATCC 29212 (MIC 32 uM), E. coli ATCC 11755 (MIC 8 uM), P. aeruginosa ATCC 27853 (MIC 16 uM), and C. albicans ATCC 10231 (MIC 4 uM). MBC are the same or 2-fold higher, indicating bactericidal.In addition, it inhibited formation of biofilms:bacteria (MBIC: 4-64 uM) and disrupted preformed biofilms at higher concentrations (MBEC: 32-128 uM against these bacteria.Der-PS4 also inhibted the proliferation of cancer cells.In vitro toxicity: horse RBC: HC50 ~128 uM. It started to show hemolysis at 16 uM.MOA:bacteria: Also MOA:fungi:C. albicans: membrane permeated.Structure:  random coil in ammoniium acetate and helical in 50% TFE, PC/PG, or PE/PG vesicles (1:1).",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_18938",
                    "Similarity": 1.0,
                    "Sequence": "ALWKTLLKHVGKAAGKAALNAVTDMVNQ"
                },
                {
                    "SPADE_ID": "SPADE_N_01172",
                    "Similarity": 0.9642857142857143,
                    "Sequence": "ALWKTLLKNVGKAAGKAALNAVTDMVNQ"
                },
                {
                    "SPADE_ID": "SPADE_N_06874",
                    "Similarity": 0.9285714285714286,
                    "Sequence": "ALWKSLLKNVGKAAGKAALNAVTDMVNQ"
                }
            ]
        }
    }
}